{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T05:24:25Z","timestamp":1743312265205},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[1995,2,1]],"date-time":"1995-02-01T00:00:00Z","timestamp":791596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,6,28]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>Twenty residue peptides from the 185\u2013200-kD and 45-kD merozoite surface antigens of the malaria parasite Plasmodium falciparum were covalently linked to diphtheria toxoid as a carrier and used to immunize human volunteers with aluminium hydroxide as an adjuvant. Significant antibody levels were elicited by two boosting injections. The antibodies reacted with acetone-methanol fixed merozoite membranes in an immunofluorescence assay, but no inhibition of merozoite reinvasion could be detected in in vitro cultures containing the antibodies. Antibody levels against the immunizing peptides declined markedly within 77 days after the third injection. No hypersensitivity was observed against the peptides. However, the volunteers developed hypersensitivity against diphtheria toxoid, and in particular a pronounced type III (Arthus) hypersensitivity after three injections with the toxoid. This effect might appear to limit the use of peptide\u2013diphtheria toxoid conjugates for human immunization. Several biochemical, haematological and immunological tests done on the volunteers showed no other adverse effects from the immunizations.<\/jats:p>","DOI":"10.1111\/j.1365-2249.1995.tb05528.x","type":"journal-article","created":{"date-parts":[[2010,7,27]],"date-time":"2010-07-27T10:00:53Z","timestamp":1280224853000},"page":"168-174","source":"Crossref","is-referenced-by-count":13,"title":["Antibody and clinical responses in volunteers to immunization with malaria peptide\u2013diphtheria toxoid conjugates"],"prefix":"10.1093","volume":"99","author":[{"given":"R","family":"Ramasamy","sequence":"first","affiliation":[{"name":"Division of Life Sciences, Institute of Fundamental Studies, Kandy, Sri Lanka"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DA","family":"Wijesundere","sequence":"additional","affiliation":[{"name":"Division of Life Sciences, Institute of Fundamental Studies, Kandy, Sri Lanka"},{"name":"Sri Jayawardenapura Hospital, Kotte, Sri Lanka"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Nagendran","sequence":"additional","affiliation":[{"name":"Division of Life Sciences, Institute of Fundamental Studies, Kandy, Sri Lanka"},{"name":"Department of Parasitology, Faculty of Medicine, University of Jaffna, Jaffna, Sri Lanka"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MS","family":"Ramasamy","sequence":"additional","affiliation":[{"name":"Division of Life Sciences, Institute of Fundamental Studies, Kandy, Sri Lanka"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2008,6,28]]},"reference":[{"key":"2022011517431052400_b1","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/328257a0","article-title":"Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites","volume":"328","author":"Herrington","year":"1987","journal-title":"Nature"},{"key":"2022011517431052400_b2","doi-asserted-by":"crossref","first-page":"626","DOI":"10.4049\/jimmunol.140.2.626","article-title":"Assessment in humans of a synthetic peptide-based vaccine against the sporozoite stage of the human malaria parasite, Plasmodium falciparum","volume":"140","author":"Etlinger","year":"1988","journal-title":"J Immunol"},{"key":"2022011517431052400_b3","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/332158a0","article-title":"A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malaria","volume":"332","author":"Patarroyo","year":"1988","journal-title":"Nature"},{"key":"2022011517431052400_b4","doi-asserted-by":"crossref","first-page":"424","DOI":"10.4269\/ajtmh.1993.48.424","article-title":"Immunogenicity of the Plasmodium falciparum asexual blood stage synthetic peptide vaccine SPf66","volume":"48","author":"Millet","year":"1993","journal-title":"Am J Trop Med Hyg"},{"key":"2022011517431052400_b5","first-page":"1278","article-title":"Safety and efficacy of a recombinant DNA Plasmodium falciparum sporozoite vaccine","volume":"1","author":"Ballou","year":"1987","journal-title":"Lancet"},{"key":"2022011517431052400_b6","doi-asserted-by":"crossref","first-page":"695","DOI":"10.4269\/ajtmh.1991.45.695","article-title":"Safety and immunogenicity of a recombinant sporozoite malaria vaccine against Plasmodium vivax","volume":"45","author":"Herrington","year":"1991","journal-title":"Am J Trop Med Hyg"},{"key":"2022011517431052400_b7","doi-asserted-by":"crossref","first-page":"533","DOI":"10.4269\/ajtmh.1991.45.533","article-title":"Phase 1 clinical trial of a recombinant malaria vaccine consisting of the circumsporozoite repeat region of Plasmodium falciparum coupled to hepatitis B surface antigen","volume":"45","author":"Vreden","year":"1991","journal-title":"Am J Trop Med Hyg"},{"key":"2022011517431052400_b8","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0264-410X(92)90009-9","article-title":"The first field trials of the chemically synthesised malaria vaccine SPf66: safety, immunogenicity and protectivity","volume":"10","author":"Amador","year":"1992","journal-title":"Vaccine"},{"key":"2022011517431052400_b9","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/0140-6736(93)90483-W","article-title":"Vaccination with SPf 66, a chemically synthesised vaccine against Plasmodium falciparum malaria in Colombia","volume":"341","author":"Valero","year":"1993","journal-title":"Lancet"},{"key":"2022011517431052400_b10","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1084\/jem.160.2.624","article-title":"The three major antigens on the surface of Plasmodium falciparum merozoites are derived from a single high molecular weight precursor","volume":"160","author":"Holder","year":"1984","journal-title":"J Exp Med"},{"key":"2022011517431052400_b11","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1073\/pnas.84.9.3014","article-title":"Merozoite surface precursor protein completely protects Aotus monkeys against Plasmodium falciparum malaria","volume":"84","author":"Siddiqui","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022011517431052400_b12","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/icb.1987.48","article-title":"Studies on glycoproteins in the human malaria parasite Plasmodium falciparum. Identification of a 45 kDa myristilated merozoite membrane glycoprotein","volume":"65","author":"Ramasamy","year":"1987","journal-title":"Immunol Cell Biol"},{"key":"2022011517431052400_b13","doi-asserted-by":"crossref","first-page":"5195","DOI":"10.1073\/pnas.85.14.5195","article-title":"Identification of two integral membrane proteins of Plasmodium falciparum","volume":"85","author":"Smythe","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022011517431052400_b14","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1084\/jem.172.1.379","article-title":"A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion inhibiting antibodies","volume":"172","author":"Blackman","year":"1990","journal-title":"J Exp Med"},{"key":"2022011517431052400_b15","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0165-2478(90)90077-4","article-title":"Characterisation of an inhibitory monoclonal antibody defined epitope on a malaria vaccine candidate antigen","volume":"23","author":"Ramasamy","year":"1990","journal-title":"Immunol Lett"},{"key":"2022011517431052400_b16","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0140-6736(88)92117-4","article-title":"Phase 1 clinical trial of a World Health Organisation birth control vaccine","volume":"1","author":"Jones","year":"1988","journal-title":"Lancet"},{"key":"2022011517431052400_b17","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1002\/j.1460-2075.1985.tb04154.x","article-title":"Polymorphism of the precursor for the major surface antigens of Plasmodium falciparum merozoites: studies at the genetic level","volume":"4","author":"Mackay","year":"1985","journal-title":"EMBO J"},{"key":"2022011517431052400_b18","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1021\/ja00897a025","article-title":"Peptide synthesis 1. The synthesis of a tetrapeptide","volume":"85","author":"Merrifield","year":"1963","journal-title":"J Am Chem Soc"},{"key":"2022011517431052400_b19","first-page":"21","article-title":"Influence of N-terminal amino acids and conjugation position to carrier on specificities of antibodies elicited by malaria peptides","volume":"99","author":"Ramasamy","year":"1994","journal-title":"Indian J Med Res"},{"key":"2022011517431052400_b20","doi-asserted-by":"crossref","first-page":"3824","DOI":"10.1073\/pnas.78.6.3824","article-title":"Prediction of protein antigen determinants from amino acid sequences","volume":"78","author":"Hopp","year":"1981","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022011517431052400_b21","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/0076-6879(89)78041-1","article-title":"Computer prediction of B-cell determinants from protein amino acid sequences based on incidence of \u03b2 turns","volume":"178","author":"Krchnak","year":"1989","journal-title":"Meth Enzymol"},{"key":"2022011517431052400_b22","first-page":"125","article-title":"Peptides derived from a malaria parasite surface antigen\u2014effect of adjuvants and number of immunisations on the total antibody response in mice","volume":"21","author":"Ramasamy","year":"1993","journal-title":"J Natn Sci Coun Sri Lanka"},{"key":"2022011517431052400_b23","doi-asserted-by":"crossref","first-page":"537","DOI":"10.4269\/ajtmh.1994.50.537","article-title":"Antibodies to epitopes on merozoite and sporozoite surface antigens as serologic markers of malaria transmission\u2014studies at a site in the dry zone of Sri Lanka","volume":"50","author":"Ramasamy","year":"1994","journal-title":"Am J Trop Med Hyg"},{"key":"2022011517431052400_b24","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0166-6851(87)90189-7","article-title":"Fragments of the polymorphic Mr 185 000 glycoprotein from the surface of isolated Plasmodium falciparum merozoites form an antigenic complex","volume":"23","author":"McBride","year":"1987","journal-title":"Mol Biochem Parasitol"},{"key":"2022011517431052400_b25","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0264-410X(93)90072-6","article-title":"Reduction of disulphide bonds in Plasmodium falciparum gp195 abolishes the production of growth- inhibitory antibodies","volume":"11","author":"Locher","year":"1993","journal-title":"Vaccine"},{"key":"2022011517431052400_b26","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/0161-5890(80)90145-5","article-title":"A method for preparing \u03b2-hCG peptide-carrier conjugates of predictable composition","volume":"17","author":"Lee","year":"1980","journal-title":"Mol Immunol"},{"key":"2022011517431052400_b27","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0166-6851(88)90067-9","article-title":"Isolation and partial characterization of a 26 kDa antigen from Plasmodium falciparum recognized by an inhibitory monoclonal antibody","volume":"29","author":"Ramasamy","year":"1988","journal-title":"Mol Biochem Parasitol"},{"key":"2022011517431052400_b28","first-page":"584","article-title":"Binding of normal immunoglobulin to the human malaria parasite Plasmodium falciparum","volume":"87","author":"Ramasamy","year":"1988","journal-title":"Indian J Med Res"},{"key":"2022011517431052400_b29","first-page":"210","article-title":"Synthetic peptides in malaria research","volume":"4","author":"Ramasamy","year":"1991","journal-title":"Pept Res"},{"key":"2022011517431052400_b30","doi-asserted-by":"crossref","first-page":"691","DOI":"10.4269\/ajtmh.1992.46.691","article-title":"Immunogenicity and efficacy trials in Aotus nancymai monkeys with model compounds representing parts of a 75 kD merozoite surface antigen of Plasmodium falciparum","volume":"46","author":"Sharma","year":"1992","journal-title":"Am J Trop Med Hyg"},{"key":"2022011517431052400_b31","doi-asserted-by":"crossref","first-page":"548","DOI":"10.4049\/jimmunol.149.2.548","article-title":"A carboxyl terminal fragment of Plasmodium falciparum gp 195 expressed by a recombinant baculovirus induces antibodies that completely inhibit parasite growth","volume":"149","author":"Chang","year":"1992","journal-title":"J Immunol"},{"key":"2022011517431052400_b32","doi-asserted-by":"crossref","first-page":"432","DOI":"10.4049\/jimmunol.132.1.432","article-title":"In vitro and in vivo studies on protective and inhibitory antibodies against Plasmodium falciparum in the Saimiri monkey","volume":"132","author":"Fandeur","year":"1984","journal-title":"J Immunol"},{"key":"2022011517431052400_b33","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1365-2249.1991.tb08134.x","article-title":"Studies on the humoral immune response to a synthetic vaccine against Plasmodium falciparum malaria","volume":"84","author":"Salcedo","year":"1991","journal-title":"Clin Exp Immunol"},{"key":"2022011517431052400_b34","first-page":"469","article-title":"Vaccines against the sporozoite stage of Plasmodium falciparum. 1 P. falciparum circumsporozoite synthetic peptide vaccine","volume-title":"New generation vaccines","author":"Nardin","year":"1990"},{"key":"2022011517431052400_b35","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1126\/science.1696030","article-title":"Use of prior vaccination for the development of new vaccines","volume":"249","author":"Etlinger","year":"1990","journal-title":"Science"},{"key":"2022011517431052400_b36","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/336778a0","article-title":"A malaria T-cell epitope recognized in association with most mouse and human MHC class II molecules","volume":"336","author":"Sinigaglia","year":"1988","journal-title":"Nature"},{"key":"2022011517431052400_b37","doi-asserted-by":"crossref","first-page":"9084","DOI":"10.1073\/pnas.86.23.9084","article-title":"Vaccine engineering: enhancement of immunogenicity of synthetic peptide vaccines related lo hepatitis in chemically defined models consisting of T- and B-cell epitopes","volume":"86","author":"Tam","year":"1989","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.1995.tb05528.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/99\/2\/168\/42202006\/j.1365-2249.1995.tb05528.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/99\/2\/168\/42202006\/j.1365-2249.1995.tb05528.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T10:39:49Z","timestamp":1685702389000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/99\/2\/168\/6484245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,2]]},"references-count":37,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2008,6,28]]},"published-print":{"date-parts":[[2008,6,28]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.1995.tb05528.x","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[1995,2]]},"published":{"date-parts":[[1995,2]]}}}